After catching Europe unprepared, the COVID-19 pandemic has created a window of opportunity to create a “European Health Union”. And what was once a long-simmering initiative has picked up steam with a formal endorsement from the European Commission’s President Ursula von der Leyen, as well as proposals to strengthen Europe’s health security. But a group […] Continue reading ->
Thirteen African countries and an international network of research institutions have joined forces to launch a multi-country clinical trial of COVID-19 drug treatments in Africa for people who are mild to moderately ill. The new ANTICOV trial, led by the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) aims to respond to the urgent need to […] Continue reading ->
The vaccine zero hour is approaching. As Norway’s Minister of International Development Dag Ulstein and South Africa’s Minister of Health Zweili Mkhize made yet another urgent plea Monday for some US$4.3 billion right now and another $US23.9 billion in 2021 to massively roll out new COVID19 vaccines, drugs and tests that are now coming on […] Continue reading ->
AstraZeneca, the pharma firm developing a COVID-19 vaccine in collaboration with researchers at Oxford University, announced that its Phase 3 clinical trials had resulted in a 90% efficacy rate for one dosing regime, in interim results released on Monday. The AstraZeneca breakthrough is significant because the vaccine, based on a known vaccine delivery technology, is […] Continue reading ->
This week is World Antimicrobial Awareness Week, marking the fight against the silent and rising global threat of antimicrobial-resistant superbugs. Can patients be part of the solution? This week is the World Antimicrobial Awareness Week (WAAW) when we turn the world’s attention to the growing problem of drug resistant diseases – caused by bacteria, viruses […] Continue reading ->
WHO on Friday issued formal guidelines recommending against the use of remdesivir for COVID-19 patients, based on a  lack of evidence that the antiviral drug, developed by Gilead, significantly improves patient outcomes. The recommendation followed publication of trial results on the drug in the The BMJ  involving more than 7,000 patients who had been hospitalized […] Continue reading ->
The tobacco industry has been exploiting the COVID-19 pandemic and resulting health sector resource shortages to gain a stronger foothold in the policy corridors of many national governments – making huge donations of PPE and other desperately needed goods, new research has shown. The Global Tobacco Industry Interference Index 2020, released by STOP (Stopping Tobacco […] Continue reading ->
COVID-19 and non-communicable diseases (NCDs) are combining as a “syndemic” that reinforce each other and disproportionately impact the most vulnerable communities in every country during the pandemic period, said experts at a NCD Alliance panel on Thursday.  However, primary health care workers, particularly nurses, who are the backbone of routine NCD responses have been particularly […] Continue reading ->